ask="N/A"
ask_size="N/A"
average_daily_volume="179787"
bid="N/A"
bid_size="N/A"
book_value="0.33"
change="N/A"
change_from_200_day_moving_average="-0.62"
change_from_50_day_moving_average="-0.17"
change_from_52_week_high="-2.34"
change_From_52_week_low="0.34"
change_in_percent="N/A"
close="1.14"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.81"
ebitda="-19.61M"
eps_estimate_current_year="-0.72"
eps_estimate_next_quarter="-0.15"
eps_estimate_next_year="-0.62"
ex_dividend_date="N/A"
float_shares="25247000"
high="N/A"
high_52_weeks="3.48"
last_trade_date="2/13/2017"
last_trade_price="1.14"
last_trade_size="N/A"
last_trade_time="3:59pm"
low="N/A"
low_52_weeks="0.80"
market_capitalization="28.98M"
moving_average_200_day="1.76"
moving_average_50_day="1.31"
name="Repros Therapeutics Inc."
notes="N/A"
one_year_target_price="5.25"
open="N/A"
pe_ratio="N/A"
peg_ratio="-0.06"
percent_change_from_200_day_moving_average="-35.25%"
percent_change_from_50_day_moving_average="-13.08%"
percent_change_from_52_week_high="-67.24%"
percent_change_from_52_week_low="+42.50%"
previous_close="1.14"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.42"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="25425000"
short_ratio="4.86"
stock_exchange="NCM"
symbol="RPRX"
volume="0"
weeks_range_52="0.80 - 3.48"
